Nutr Res Pract.  2024 Feb;18(1):62-77. 10.4162/nrp.2024.18.1.62.

Combination of oxaliplatin and β-carotene suppresses colorectal cancer by regulating cell cycle, apoptosis, and cancer stemness in vitro

• Lee J
• Heo SC
• Kim Y

• KMID: 2552280
• DOI: http://doi.org/10.4162/nrp.2024.18.1.62

Abstract

BACKGROUND/OBJECTIVES
Colorectal cancer (CRC) is the third most common cancer worldwide with a high recurrence rate. Oxaliplatin (OXA) resistance is one of the major reasons hindering CRC therapy. β-Carotene (BC) is a provitamin A and is known to have antioxidant and anticancer effects. However, the combined effect of OXA and BC has not been investigated. Therefore, this study investigated the anticancer effects and mechanism of the combination of OXA and BC on CRC.
MATERIALS/METHODS
In the present study, the effects of the combination of OXA and BC on cell viability, cell cycle arrest, and cancer stemness were investigated using HCT116, HT29, OXA-resistant cells, and human CRC organoids.
RESULTS
The combination of OXA and BC enhanced apoptosis, G _{2,/sub> /M phase cell cycle arrest, and inhibited cancer cell survival in human CRC resistant cells and CRC organoids without toxicity in normal organoids. Cancer stem cell marker expression and self-replicating capacity were suppressed by combined treatment with OXA and BC. Moreover, this combined treatment upregulated apoptosis and the stem cell-related JAK/STAT signaling pathway.
CONCLUSIONS
Our results suggest a novel potential role of BC in reducing resistance to OXA, thereby enhances the anticancer effects of OXA. This enhancement is achieved through the regulation of cell cycle, apoptosis, and stemness in CRC.}

Keyword

Beta-carotene; oxaliplatin; colorectal neoplasm; organoids; cell cycle